切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2018, Vol. 07 ›› Issue (02) : 137 -140. doi: 10.3877/cma.j.issn.2095-3224.2018.02.007

所属专题: 文献

论著

二甲双胍对高葡萄糖环境下结肠癌细胞增殖和侵袭的影响
刘付俊业1, 吴共发2,(), 邱丽浈3, 曾宇婷2, 黄绮亭2   
  1. 1. 518109 深圳市龙华区人民医院消化内科
    2. 511300 广州市增城区人民医院(中山大学孙逸仙纪念医院增城院区)病理科
    3. 511300 广州市增城区人民医院(中山大学孙逸仙纪念医院增城院区)内三科
  • 收稿日期:2017-06-10 出版日期:2018-04-25
  • 通信作者: 吴共发
  • 基金资助:
    广东省医学科研基金(No.A2016422)

Effects of metformin on proliferation and invasion in colon carcinoma cell in the high glucose environment

Junye Liufu1, Gongfa Wu2,(), Lizhen Qiu3, Yuting Zeng2, Qiting Huang2   

  1. 1. Department of Gastroenterology, Longhua District People′s Hospital of Shenzhen City, Shenzhen 518109, China
    2. Department of Pathology, Zengcheng District People′s Hospital of Guangzhou City, Guangzhou 511300, China
    3. Third Department of Internal Medicine, Zengcheng District People′s Hospital of Guangzhou City, Guangzhou 511300, China
  • Received:2017-06-10 Published:2018-04-25
  • Corresponding author: Gongfa Wu
  • About author:
    Corresponding author: Wu Gongfa, Email:
引用本文:

刘付俊业, 吴共发, 邱丽浈, 曾宇婷, 黄绮亭. 二甲双胍对高葡萄糖环境下结肠癌细胞增殖和侵袭的影响[J/OL]. 中华结直肠疾病电子杂志, 2018, 07(02): 137-140.

Junye Liufu, Gongfa Wu, Lizhen Qiu, Yuting Zeng, Qiting Huang. Effects of metformin on proliferation and invasion in colon carcinoma cell in the high glucose environment[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2018, 07(02): 137-140.

目的

观察二甲双胍在高葡萄糖环境下对人结肠癌细胞系SW480增殖和侵袭的影响,并探讨其可能的机制。

方法

通过Western blot方法检测SW480细胞在高葡萄糖及不同浓度二甲双胍干预后E-cadherin和Vimentin的表达水平,并应用CCK-8法及Transwell侵袭实验检测细胞增殖及侵袭能力的变化。

结果

高葡萄糖作用不同时间后均能促进结肠癌细胞增殖,二甲双胍能抑制结肠癌细胞的增殖,并呈时间——剂量依赖性。20 mmol/L浓度二甲双胍干预48 h后,Transwell侵袭实验结果显示细胞穿膜数为(40.18±2.22)%,明显低于高糖组和对照组(F=49.403,P<0.001);Western blot结果显示E-cadherin表达明显增强,Vimentin表达明显减弱。

结论

高葡萄糖环境能促进结肠癌细胞生长,二甲双胍能明显抑制有或无高葡萄糖环境下结肠癌的增殖和侵袭能力,其机制可能与调节上皮——间质转化(EMT)过程有关。

Objective

To investigate the effects of metformin on proliferation and invasion in human colon carcinoma cell SW480 in the high glucose environment and explore the possible underlying mechanisms.

Methods

Western blot was applied to assess the expressions of E-cadherin and Vimentin in SW480 cells treated with high glucose medium and different concentration metformin, respectively. Cell proliferation and invasion were detected by Cell Counting Kit-8 (CCK-8) assay and transwell invasion assay, respectively.

Results

High glucose could promote proliferation of SW480 cells at different action time. After intervened by different concentration of metformin, metformin decreased the proliferation of SW480 in a dose-and time dependent manner. Comparing with the high glucose group and control group, after 48 h of metformin (20 mmol/L) intervention to SW480, transwell invasion assay indicated that the cells crossing the membrane were significantly decreased to (40.18±2.22)% (F=49.403, P<0.001). Western blot showed that the expressions of E-cadherin were obviously increased, while Vimentin were apparently decreased.

Conclusion

High glucose environment can promote the growth of colon carcinoma cells. Metformin causes a distinct reduction of cells proliferation and invasion in colon carcinoma cells with or without high glucose environment, its molecular mechanism may involve in metformin have a role in the regulation of epithelial-mesenchymal transition.

图1 高糖组与对照组不同时间点的细胞增殖情况
图2 不同浓度二甲双胍对高糖环境下SW480细胞的增殖影响
图3 二甲双胍对高糖环境下结肠癌细胞EMT标记物的表达影响
[1]
Lee MS, Hsu CC, Wahlqvist ML, et al. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancerinc idences in Taiwanese: a representative population prospective cohort study of 800, 000 individuals [J]. BMC Cancer, 2011, 11: 20
[2]
Nie Z, Zhu H, Gu M. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis [J]. Pharm Biol, 2016, 54(11): 2636-2642.
[3]
de Kort S, Simons CC, van den Brandt PA, et al. Diabetes mellitustype 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer [J]. Eur J Gastroenterol Hepatol, 2016, 28(8): 896-903.
[4]
Coyle C, Cafferty FH, Vale C, et al. Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis [J]. Ann Oncol, 2016, 27(12): 2184-2195.
[5]
Zakikhani M, Dowling RJ, Sonenberg N, et al. The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase [J]. Cancer Prev Res(Phila), 2008, 1(5): 369-375.
[6]
Tomimoto A, Endo H, Sugiyama M, et al. Metformin suppresses intestinal polyp growth in ApcMin/+ mice [J]. Cancer Sci, 2008, 99(11): 2136-2141.
[7]
朱智峰,梁琳琅. 二甲双胍对结肠癌细胞增殖、周期及凋亡的影响 [J]. 中国医科大学学报, 2012, 41(2): 115-119.
[8]
郭娜,逢曙光. 二甲双胍抑制晚期糖基化终产物诱导的大肠癌细胞侵袭和上皮间质转化 [J]. 中国老年学杂志, 2015, 35(19): 5374-5377.
[9]
Ben Sahra I, Laurent K, Loubat A, et al. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level [J]. Oncogene, 2008, 27(25): 3576-3586.
[10]
王静璐,史惠蓉,谢娅, 等.二甲双胍对不同分化程度的子宫内膜癌细胞增殖的影响及相关作用机制 [J]. 中华妇产科杂志, 2015, 65(9): 685-691.
[11]
Yeung KT, Yang J. Epithelial-mesenchymal transition in tumor metastasis [J]. Mol Oncol, 2017, 11(1): 28-39.
[12]
Valaee S, Yaghoobi MM, Shamsara M. Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner [J]. PLoS One, 2017, 12(3): e0174486.
[13]
Zhao Z, Cheng X, Wang Y, et al. Metformin inhibits theIL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis [J]. PLoS One, 2014, 9(4): e95884.
[1] 向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[2] 毛书雷, 张元海, 王杰, 倪良方, 王新刚, 邹雁, 王荣娟, 吴军梅, 张建芬. 区域性静脉灌注葡萄糖酸钙治疗手指氢氟酸烧伤的临床疗效和安全性分析[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 386-392.
[3] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[4] 祝炜安, 林华慧, 吴建杰, 黄炯煅, 吴婷婷, 赖文杰. RDM1通过CDK4促进前列腺癌细胞进展的研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 618-625.
[5] 赵旭鹏, 王集琛, 田硕, 李宏召, 李修彬, 张旭. EP300 通过上调FKBP10 促进膀胱肿瘤细胞迁移和侵袭[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 264-274.
[6] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[7] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[8] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[9] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[10] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[11] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[12] 程柏凯, 杨光. 高胰岛素-正葡萄糖钳夹技术评估慢性肾脏病患者胰岛素抵抗的研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 334-339.
[13] 施麟宵, 洪兰兰, 阳柳, 芶碧珍, 刘畅, 吴欣. 钠-葡萄糖协同转运蛋白2 抑制剂治疗原发性膜性肾病的疗效及其对Th1/Th2 的影响[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 261-267.
[14] 王国强, 张纲, 唐建坡, 张玉国, 杨永江. LINC00839 调节miR-17-5p/WEE1 轴对结直肠癌细胞增殖、凋亡和迁移的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 491-499.
[15] 靳英, 付小霞, 陈美茹, 袁璐, 郝力瑶. CD147调控MAPK信号通路对结肠癌细胞增殖和凋亡的影响及机制研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 474-480.
阅读次数
全文


摘要